This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
SUPS 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
ASCO 2024
ASCO 2024 Bladder Cancer
ASCO 2024
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular and Penile Cancer
Upper Tract Urothelial Carcinoma
Press Releases
ASCO 2024 Bladder Cancer
Viewing 8981-9000 of 11531 articles
AUA 2017: Relationship Between Quality of Life and Overall Survival in Metastatic Castration-Resistant Prostate cancer patients in ALSYMPCA: Analysis by Prior Docetaxel Subgroup
AUA 2017: Population-based analysis in treatment toxicity among men with castration-resistant prostate cancer
AUA 2017: Late-Breaking Abstract- Blue Light Flexible Cystoscopy (BLFC) with Hexaminolevulinate (HAL) and White Light Flexible cystoscopy: A Prospective, Comparative, Within-Patient controlled Multi-Center Phase 3 Study in the Detection of Bladder Cancer
AUA 2017: Novel therapies targeting androgen receptor variant in an in vitro model of castrate resistant prostate cancer.
AUA 2017: Panel Discussion: Advances in Imaging in Urologic Oncology
AUA 2017: A Comparison of Post-Cystectomy Recurrence and Survival in NAC-Responsive MIBC vs. High-Risk NMIBC Patients
AUA 2017: Validation of VTE Score in Major Urologic Cancer Surgery
AUA 2017: Is compliance to an enhanced recovery protocol after radical cystectomy associated with improved post operative outcomes?
AUA 2017: NHANES: Nearly Half of US Men Test Positive for HPV, Yet Vaccination Rates Lag and Recommendations Demur
AUA 2017: Risk of hospitalization following outpatient prostate brachytherapy
AUA 2017: Prostate fiducial marker placement in patients while on anticoagulation: feasibility prior to prostate SBRT
AUA 2017: Long-term Survival in Men with Gleason Score 9-10 Treated with Prostate Brachytherapy and External Beam Irradiation
AUA 2017: Effectiveness of combination therapy of external-beam radiation and high dose-rate brachytherapy for high-risk prostate carcinoma
AUA 2017: Prognostic Utility of Biopsy-Derived Cell Cycle Progression Score in Patients with NCCN Low-Risk Prostate Cancer Undergoing Radical Prostatectomy: Implications for Treatment Guidance
AUA 2017: Transrectal prostate biopsy after prophylatic preparation of the rectum with povidone-iodine- A prospective randomized trial
AUA 2017: Big Renal Angiomyolipoma: The 4 cm size limit for conservative management should be revisited?
AUA 2017: A Multi-Institutional Propensity Score Matched Comparison of Transperitoneal vs. Retroperitoneal Robotic Partial Nephrectomy for Posterior Clinical T1 Renal Masses
AUA 2017: Impact of Renal Vein Invasion on the Outcome in Patient with Renal Cell Carcinoma and Caval Thrombus
AUA 2017: Renal Mass Biopsy is Associated with increased Incidence of Pathological Upstaging to Perinephric Fat Invasion in Patient with Clinically Localized Renal Cell Carcinoma.
AUA 2017: Quantitative Digital Image Analysis and Machine Learning Accurately Classifies Primary Prostate Tumors of Bone Metastatic Disease Based on Histomorphometric Features in Diagnostic Prostate Needle Biopsies
445
446
447
448
449
450
451
452
453
454
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free